Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
4 studies found for:    16606972 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Chemotherapy in Treating Women With Breast Cancer That Can Be Surgically Removed
Condition: Breast Cancer
Interventions: Drug: Cyclophosphamide;   Drug: Docetaxel;   Drug: Doxorubicin;   Drug: Tamoxifen
2 Recruiting Sequential Neo-adjuvant Chemotherapy Followed by Capecitabine Vs. Conventional Adjuvant Chemotherapy in Breast Cancer
Condition: Breast Neoplasm Female
Interventions: Procedure: Neo-adjuvant Chemotherapy;   Drug: Capecitabine
3 Active, not recruiting Study of the Response to a Neoadjuvant Chemotherapy Based on the Antitumor Immune Response in Localized Breast Cancer
Condition: Breast Cancer
Intervention: Biological: Blood and tumor sample
4 Recruiting Explore the Individual Treatment of Docetaxel and Paclitaxel in NSCLC, NPC and BRC by PK-guided Dosing Strategy
Conditions: Non-small Cell Lung Cancer;   Breast Cancer;   Nasal Cancer
Interventions: Device: PK guided arm;   Drug: PTX 175mg/m2, DOC 75mg/m2

Study has passed its completion date and status has not been verified in more than two years.